Description

Perrigo’s 17% Short Interest Meets Takeover Buzz: Is Wall Street Underestimating Something?

Perrigo Company is back in the takeover spotlight, and its heavily shorted stock adds another layer of intrigue. Reports on October 9 suggested that private equity firm CVC Capital Partners could be evaluating a potential acquisition of Perrigo to combine it with Cooper Consumer Health. The speculation follows earlier reports linking German pharmaceutical company Stada Arzneimittel and its majority owner, CapVest, to a possible bid. Perrigo shares climbed approximately 4% on October 9, closing at $15.06, while its reported short interest of around 16% highlighted substantial bearish positioning. More recent short-interest data covering September 30 indicated an even higher 17.54% of the public float. Beyond the rumors, Perrigo is undergoing a restructuring involving asset sales, debt reduction, operational improvements and strategic portfolio reviews.